Glenmark Life Sciences Limited (GLS.NS) - Quarterly Income Statement

Home
GLS.NS
Financials

1096.1 (INR) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	5,068.79	5,886.16	5,365.97	5,728.04	5,953.63	5,784.5	6,213.2	5,407.31	5,092.99	4,898.7	5,140.57	5,224.99	5,617.61	5,248.97	4,671.63	5,002.29	5,208.05	3,969.68
Cost of Revenue Numbers are in millions	2,251.96	3,590.2	2,386.99	2,421.92	2,730.8	2,480.39	2,803.78	2,648.33	2,399.77	2,289	2,551.25	2,571.72	2,712.17	2,593.73	1,924.7	2,436.15	2,939.75	1,754.37
Gross Profit Numbers are in millions	2,816.83	2,295.96	2,978.98	3,306.12	3,222.83	3,304.11	3,409.42	2,758.98	2,693.22	2,609.7	2,589.32	2,653.27	2,905.44	2,655.24	2,746.93	2,566.14	2,268.3	2,215.31
Gross Profit Ratio Numbers are in millions	0.556	0.39	0.555	0.577	0.541	0.571	0.549	0.51	0.529	0.533	0.504	0.508	0.517	0.506	0.588	0.513	0.436	0.558
Reseach & Development Expenses Numbers are in millions	0	0	0	184	0	0	651.77	167.6	168.6	0	571.96	153.9	181.4	0	101.62	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	0	816.91	0	0	0	393.03	0	0	0	375.05	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	90.07	0	0	0	54.96	0	0	0	9.98	0	0	0
SG&A Numbers are in millions	848.85	844.98	841.96	686.03	884.85	481.32	906.98	651.41	614.54	404.56	447.99	441.31	485.67	681.34	385.03	376.37	424.84	315.2
Other Expenses Numbers are in millions	1,624.17	54.93	31.31	16.91	53.69	18.51	28.36	66.08	100.2	94.93	-92.9	35.34	20.89	39.86	-0.89	3.72	0.12	0
Operating Expenses Numbers are in millions	1,624.17	844.98	1,709.87	1,712.33	1,683.28	1,498.62	1,460.29	1,412.05	1,356.18	1,240.81	1,255.32	1,290.02	1,328.72	1,139.95	1,091.91	1,101.46	1,082.61	902.61
Operating Income Numbers are in millions	1,192.66	1,450.98	1,300.42	1,610.7	1,593.24	1,805.49	1,977.49	1,413.01	1,437.24	1,368.89	1,334	1,363.25	1,576.72	1,555.15	1,618	1,468.4	1,185.81	1,295.4
Operating Income Ratio Numbers are in millions	0.235	0.247	0.242	0.281	0.268	0.312	0.318	0.261	0.282	0.279	0.26	0.261	0.281	0.296	0.346	0.294	0.228	0.326
Total Other Income Expenses Net Numbers are in millions	81.9	51.4	-3.64	-3.87	-3.99	14.55	-1.19	-1.6	-1.33	93.58	42.27	34.73	-51.37	-205.5	-211.78	-216.5	-219.04	-210.85
Income Before Tax Numbers are in millions	1,274.56	1,502.38	1,296.78	1,606.83	1,589.25	1,820.04	1,976.3	1,411.41	1,435.91	1,462.47	1,376.27	1,397.98	1,525.35	1,349.65	1,406.22	1,251.9	966.77	1,084.55
Income Before Tax Ratio Numbers are in millions	0.251	0.255	0.242	0.281	0.267	0.315	0.318	0.261	0.282	0.299	0.268	0.268	0.272	0.257	0.301	0.25	0.186	0.273
Income Tax Expense Numbers are in millions	321.4	387.55	317.42	419.18	401.88	465.54	512.73	361.48	367.13	375.14	387.3	360.85	373.34	340.52	359.38	318.29	242.07	273.89
Net Income Numbers are in millions	953.16	1,114.83	979.36	1,187.65	1,187.37	1,354.5	1,463.57	1,049.93	1,068.78	1,087.33	988.97	1,037.13	1,152.01	1,009.13	1,046.84	933.61	724.7	810.66
Net Income Ratio Numbers are in millions	0.188	0.189	0.183	0.207	0.199	0.234	0.236	0.194	0.21	0.222	0.192	0.198	0.205	0.192	0.224	0.187	0.139	0.204
EPS Numbers are in millions	7.78	9.1	7.99	9.69	9.69	11.05	11.94	8.57	8.72	8.87	8.08	8.65	9.83	8.24	8.54	7.62	5.91	7.52
EPS Diluted Numbers are in millions	7.75	9.08	7.99	9.67	9.69	11.05	11.94	8.57	8.72	8.87	8.08	8.65	9.82	8.24	8.54	7.62	5.91	7.52
EBITDA Numbers are in millions	1,428.92	1,594.85	1,445.76	1,742.47	1,724.53	1,950.12	2,092.66	1,520.64	1,536.59	1,562.61	1,473.06	1,495.98	1,694.26	1,644.34	1,702.26	1,552	1,269.3	1,366.613
EBITDA Ratio Numbers are in millions	0.282	0.271	0.269	0.304	0.29	0.337	0.337	0.281	0.302	0.319	0.287	0.286	0.302	0.313	0.364	0.31	0.244	0.344

Glenmark Life Sciences Limited

NSE:GLS.NS Add to watchlist

NSE:GLS.NS